<?xml version="1.0" encoding="UTF-8"?>
<p class="p">A double-blind randomized placebo-controlled trial conducted in pregnant women, randomized to receive either 400 mg of algal DHA daily or placebo from Weeks 18â€“22 of gestation until delivery, showed that supplementation induced a significant increase of 
 <italic class="italic">IGF2</italic> Differentially-Methylated Regions (DMRs) in cord blood of infants of overweight mothers and a significant hypomethylation of H19 DMRs in infants of normal-weight mother [
 <xref rid="B93-ijms-20-02118" ref-type="bibr" class="xref">93</xref>]. Hypomethylation at 
 <italic class="italic">IGF2</italic> DMRs has been previously proposed as one mechanism linking low birth weight, a high risk of diabetes, hypertension, and other metabolic diseases.
</p>
